FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Simkoff Maxwell 2. Issuer Name and Ticker or Trading Symbol Doma Holdings, Inc. [ DOMA ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)
101 MISSION ST., SUITE 740
3. Date of Earliest Transaction (MM/DD/YYYY)
9/6/2022
(Street)
SAN FRANCISCO, CA 94105
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock  9/6/2022    S    81226 (1) D $0.546 (2) 5291560  D   
Common stock  9/6/2022    S    134109 (3) D $0.545 (4) 47119166 (5) I  By The Saslaw-Simkoff Revocable Trust 
Common stock  9/7/2022    S    25891 (3) D $0.538 (6) 47093275 (5) I  By The Saslaw-Simkoff Revocable Trust 
Common stock                 346609 (7) I  By Max Simkoff 2020 GRAT 
Common stock                 346609 (8) I  By Jennifer Saslaw 2020 GRAT 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  As previously reported, on June 29, 2022 (the "Date of Grant"), the reporting person was granted 2,435,325 restricted stock units ("RSUs") under the Doma Holdings, Inc.'s (the "Company") Omnibus Incentive Plan (the "Plan"), representing the right to receive shares of Company common stock in the future. The grant vests as follows: 1/16th of the total RSUs will vest on each successive Scheduled Vesting Date (as defined below) following the Date of Grant, with a "Scheduled Vesting Date" being September 1, December 1, March 1 and June 1 of the applicable year, provided the reporting person is continuously employed through such date as applicable, with the first 1/16th of the RSUs vesting on September 1, 2022 and the final 1/16th of the RSUs vesting on September 1, 2026. On September 1, 2022, 152,207 shares of such RSUs vested. In connection with this vesting, 81,226 shares were sold on September 6, 2022 to satisfy the reporting person's tax withholding obligations.
(2)  The price reported above in Column 4 represents a weighted average purchase price. This transaction was executed in multiple trades at prices ranging from $0.53 to $0.59, inclusive. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected.
(3)  This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
(4)  The price reported above in Column 4 represents a weighted average sales price. This transaction was executed in multiple trades at prices ranging from $0.53 to $0.59, inclusive. The reporting person hereby undertakes to provide, upon request, to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected.
(5)  These shares are owned directly by The Saslaw-Simkoff Revocable Trust and indirectly by Maxwell Simkoff as trustee of the trust. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
(6)  The price reported above in Column 4 represents a weighted average sales price. This transaction was executed in multiple trades at prices ranging from $0.53 to $0.56, inclusive. The reporting person hereby undertakes to provide, upon request, to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected.
(7)  These shares are owned directly by the Max Simkoff 2020 GRAT. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
(8)  These shares are held for the benefit of the reporting person's wife. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Simkoff Maxwell
101 MISSION ST.
SUITE 740
SAN FRANCISCO, CA 94105
X X Chief Executive Officer
Saslaw-Simkoff Revocable Trust
101 MISSION ST.
SUITE 740
SAN FRANCISCO, CA 94105

X


Signatures
/s/ Christian Ameri, as Attorney-in-Fact for Maxwell Simkoff 9/8/2022
**Signature of Reporting Person Date
/s/ Christian Ameri, as Attorney-in-Fact for Maxwell Simkoff, Trustee 9/8/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Capitol Investment Corp V (NYSE:CAP)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Capitol Investment Corp V Charts.
Capitol Investment Corp V (NYSE:CAP)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Capitol Investment Corp V Charts.